Spruce Biosciences, Inc.
SPRB
$0.0649
-$0.001-1.52%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.04M | -23.56M | -8.67M | -9.18M | -11.63M |
| Total Depreciation and Amortization | 6.00K | 9.00K | 10.00K | 12.00K | 15.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 451.00K | 1.03M | 1.20M | 1.75M | 1.62M |
| Change in Net Operating Assets | 857.00K | 1.85M | -1.76M | -3.69M | -4.97M |
| Cash from Operations | -12.73M | -20.68M | -9.22M | -11.11M | -14.96M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -405.00K | -406.00K | -405.00K | -406.00K | -405.00K |
| Issuance of Common Stock | -- | 14.00K | 0.00 | 52.00K | 180.00K |
| Repurchase of Common Stock | -- | -233.00K | 0.00 | -11.00K | -2.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -6.00K | -- | -- | -- | -- |
| Cash from Financing | -411.00K | -625.00K | -405.00K | -365.00K | -227.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.14M | -21.30M | -9.63M | -11.47M | -15.19M |